Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1

Post time 3 day(s) ago

journal：New England Journal of Medicine

Authors：Yves Dauvilliers; Giuseppe Plazzi; Emmanuel Mignot; Gert Jan Lammers; Rafael del Río Villegas; Ramin Khatami; Mitsutaka Taniguchi; Anson Abraham; Yaming Hang; Harisha Kadali; Marta Lamberton; Sarah Sheikh; Ellie Stukalin; Rachel Neuwirth; Todd J. Swick; Shinichiro Tanaka; Christian von Hehn; Philipp von Rosenstiel; Hao Wang; Alice Cai; Melissa Naylor; Tina Olsson

Published date：2025-5-15

DOI：10.1056/nejmoa2405847

PDF link：http://www.nejm.org/doi/pdf/10.1056/NEJMoa2405847

Article link：https://doi.org/10.1056/nejmoa2405847

Article Source：Massachusetts Medical Society。

Remark：

Post time 3 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[NEJM] Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[NEJM] Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1 Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[NEJM] Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1